[앵커]
China, which was focusing on the independent development of vaccines, eventually decided to import a vaccine made by German Bioentech.
I decided to buy a vaccine that is currently being vaccinated in the United States or the United Kingdom, and also in China.
Correspondent Kang Seong-woong reports from Beijing.
[기자]
A Chinese pharmaceutical company has announced that it has agreed to import a vaccine from Bioentech from Germany.
The content is that Bioentech will supply 100 million doses of Corona 19 vaccine to mainland China by next year.
Bioentech is a company that jointly developed vaccines currently being vaccinated in the US and UK with Pfizer in the US.
Virtually the same vaccine will likely be supplied to China.
Fuxing Pharmaceuticals, a Chinese pharmaceutical company that imports, said that all of its initial quantities were produced at a German factory.
Bioentech tested the vaccine in Fuxing Medicine and Jiangsu Province, China, but did not reach development.
Major Chinese pharmaceutical companies that were leading the development, such as Sino Pharm and Sino Bag, have not yet announced their achievements.
A side effect of leg paralysis during a clinical trial in Peru last week also appears to have been considered.
Peruvian health officials are still investigating the cause, having stopped testing the vaccine from China’s Sinofam.
The Brazilian government has raised questions about the criteria for emergency use of Chinese-made vaccines.
Currently, two countries that officially approve and receive vaccines from China are the United Arab Emirates and Bahrain.
However, there is concern about confusion over China’s full-fledged import decision, which promoted its own development.
As China, a large country with a population of 1.4 billion, is also importing, competition for vaccines is expected to intensify.
YTN Sungwoong Kang in Beijing[[email protected]]is.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
– .
